Biomarker Identification in Nonalcoholic Fatty Liver Disease via GC/MS

Untargeted Investigation of Non-Alcoholic Fatty Liver Disease Using Effective Mutiplatform GC-MS Instrumentation David E. Alonso1, Xiang Zhang2, Todd Richards1, and Joe Binkley1 | 1LECO Corporation, St. Joseph, Michigan | 2Department of Chemistry and Biochemistry, University of Louisville, Louisville, Kentucky Throughput:…

Effects of Increased Fructose Consumption and Inadequate Copper Intake on the Pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD): A Feces, Plasma and Liver Metabolomics Study David E. Alonso1, Biyun Shi2, Ming Song2, Xinmin Yin2, Xiaoli Wei2, Michelle Page1, Joe Binkley1,…

A Novel Benchtop Time-of-Flight GC-MS System for High Performance Analysis of Human Urine David E. Alonso, Joseph E. Binkley, Lorne M. Fell | LECO Corporation, St. Joseph, MI Results (Non-Smokers’ Urine) 1e8 2 0 Time (s) 240 260 280 300…

Application Note ® ® Instrument: Pegasus BT and ChromaTOF Sync EMPOWERING RESULTS A Comprehensive GC-TOFMS Metabolomics Workflow LECO Corporation; Saint Joseph, Michigan USA Key Words: Diabetes, Time-of-Flight Mass Spectrometry, ChromaTOF Sync Introduction The chronic disease diabetes is a result of…